Patents by Inventor Yongqing Wu

Yongqing Wu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230266973
    Abstract: Provided are a local data stream acceleration method, a data stream acceleration system, a computer device and a storage medium. The method includes the following: receiving a raw data stream collected by a data acquisition device and performing preliminary processing on the raw data stream; configuring a local data stream acceleration engine, inputting the preliminarily processed raw data stream into the data stream acceleration engine for acceleration processing, and obtaining a result of data stream acceleration processing; and outputting the result of data stream acceleration processing. The data stream acceleration engine is configured dynamically and locally according to the type of the obtained data stream, and the data stream is accelerated by the dynamically configured local data stream acceleration engine.
    Type: Application
    Filed: October 12, 2019
    Publication date: August 24, 2023
    Applicant: Shenzhen Corerain Technologies Col., Ltd.
    Inventors: Yongqing WU, Hao JIANG, Kuenhung Tsoi, Xinyu NIU
  • Publication number: 20180028477
    Abstract: The present disclosure provides novel methods for treating cardiac remodeling and heart conditions using specific compounds, as well as compositions, and pharmaceutical formulations. In some embodiments, the compounds may inhibit acetylation of MEF2 transcription factors.
    Type: Application
    Filed: October 3, 2017
    Publication date: February 1, 2018
    Inventors: Lin CHEN, Yongqing WU, Jianqin WEI, Nanette BISHOPRIC
  • Publication number: 20160271083
    Abstract: The present disclosure provides novel methods for treating cardiac remodeling and heart conditions using specific compounds, as well as compositions, and pharmaceutical formulations. In some embodiments, the compounds may inhibit acetylation of MEF2 transcription factors.
    Type: Application
    Filed: November 5, 2014
    Publication date: September 22, 2016
    Inventors: Lin CHEN, Yongqing WU, Jian WEI, Nanette BISHOPRIC
  • Publication number: 20150374646
    Abstract: The present disclosure provides novel methods for treating cancer and conditions regulatable by a transcription factor and/or cofactor using specific compounds, as well as compositions, and pharmaceutical formulations. In certain embodiments, the compounds are transcription factor modulators.
    Type: Application
    Filed: September 8, 2015
    Publication date: December 31, 2015
    Inventors: Lin CHEN, Xiaojiang CHEN, Meng XIA, Yongqing WU, Yongheng CHEN, Dahai GAI
  • Publication number: 20150284360
    Abstract: Amide derivatives of aniline-related compounds are disclosed, including salts thereof, and compositions, preparations and uses thereof. In certain embodiments, the amide derivatives and/or salts thereof show higher solubility in water compared to the corresponding parent aniline-related compounds.
    Type: Application
    Filed: April 2, 2015
    Publication date: October 8, 2015
    Inventors: Lin CHEN, Yongqing WU, Dahai GAI, Xiaojiang CHEN
  • Patent number: 9133105
    Abstract: The present disclosure provides novel compounds capable of functioning as transcription factor modulators, as well as compositions, pharmaceutical formulations, and kits. Also provided are methods of treating a condition regulatable by a transcription factor and/or cofactor using the compounds, compositions, pharmaceutical formulations, and kits provided herein.
    Type: Grant
    Filed: March 15, 2013
    Date of Patent: September 15, 2015
    Assignee: C&C BIOPHARMA, LLC
    Inventors: Lin Chen, Xiaojiang Chen, Yongqing Wu, Dahai Gai
  • Publication number: 20140256775
    Abstract: The present disclosure provides novel compounds capable of functioning as transcription factor modulators, as well as compositions, pharmaceutical formulations, and kits. Also provided are methods of treating a condition regulatable by a transcription factor and/or cofactor using the compounds, compositions, pharmaceutical formulations, and kits provided herein.
    Type: Application
    Filed: March 15, 2013
    Publication date: September 11, 2014
    Inventors: Lin CHEN, Xiaojiang CHEN, Yongqing WU, Dahai GAI
  • Publication number: 20140256776
    Abstract: The present disclosure provides novel methods for treating cancer and conditions regulatable by a transcription factor and/or cofactor using specific compounds, as well as compositions, and pharmaceutical formulations. In certain embodiments, the compounds are transcription factor modulators.
    Type: Application
    Filed: March 15, 2013
    Publication date: September 11, 2014
    Inventors: Lin CHEN, Xiaojiang CHEN, Meng XIA, Yongqing WU, Yongheng CHEN, Dahai GAI
  • Publication number: 20100005263
    Abstract: An information backup method, a firewall, and a network system are provided in the embodiments of the present disclosure. The method of the present disclosure implements information backup between at least two firewalls. The method includes: receiving a packet; and backing up changed session information to the another firewall if it is detected that the received packet causes the recorded session information to have changed. As such, session information recorded in the firewalls is consistent in real time.
    Type: Application
    Filed: May 20, 2009
    Publication date: January 7, 2010
    Applicant: Huawei Technologies Co., Ltd.
    Inventor: Yongqing Wu